Chemical industry – Page 71
-
Business
Fatal blast at US peroxide plant
One dead and three injured in an equipment explosion at PeroxyChem in Texas
-
BusinessCrispr goes commercial
Gene editing technique Crispr has shaken up genomics research and the commercial opportunities couldn’t be more evident
-
BusinessShire bets big on rare diseases
$32bn Baxalta buyout will deepen Shire’s commitment to developing specialist drugs for small patient populations
-
Business
ChemChina buys German machinery maker
Plastics and rubber equipment manufacturer KraussMaffei Group will retain German headquarters after €1bn deal
-
BusinessFixing the broken antibiotics business model
With rising resistance and doomsday warnings, focus is turning to alternative economic models to boost antibiotic R&D
-
Business
ThermoFisher will buy Affymetrix to expand genetic testing
Deal boosts Thermo’s position in growing genomics field as well as adding antibodies and assay technology
-
BusinessNew vinyl catalyst will reduce mercury emissions
Johnson Matthey strikes gold as China’s PVC industry looks for cleaner processes
-
Business
GSK’s ViiV to buy HIV drugs from BMS
Deal hands over Bristol-Myers Squibb’s entire HIV pipeline as the company looks to quit virology research
-
Business
Monsanto adds 1000 to job cut tally
Cost reduction plan brings cuts up to 16% of global workforce by the end of 2018
-
BusinessDuPont cuts go deep in Delaware
Following its merger with Dow, DuPont will terminate 1700 positions in Delaware, US, as part of a cost-cutting drive
-
BusinessShale feeds US methanol boom
US will become a net exporter as new plants come online, with extra production absorbed by growth in China
-
Business
AstraZeneca to buy Acerta for blood cancer drug
Deal will strengthen AstraZeneca’s immunotherapy offering
-
-
-
-
-
Business
Mexico approves world’s first dengue vaccine
Sanofi’s vaccine protects children and adults against the mosquito-borne disease
-
Business
BioAtla and Pfizer to collaborate on antibody research
Two-way agreement to share technology and royalties on new cancer drugs
-
